In this contemporary cohort study of intermediate- to high-risk PCa patients treated with RARP and ePLND at a tertiary cancer center, the overall sensitivity and specificity of PSMA PET/CT for detecting regional pelvic LNM were 26.3% and 93.9%, respectively. Here, FOLH1 is linked to cancer.